The French Competition Authority announces the launch of an inquiry into the pharma sector

On 26 February 2013, the French Competition Authority (“Autorité de la concurrence”) announced the launch of a pharma sector inquiry. The Autorité ’s main goal is to address the cost of prescription medicines for social security, the high prices of non-reimbursable medicines, and the low level of generic competition in France. The inquiry will focus on the distribution of medicinal products by pharmaceutical companies, wholesalers and pharmacists and will not touch upon patent settlement agreements. The Autorité will also examine the issue of online sale of medicines. In sum, the sector inquiry will focus on:

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

Quotation

Jean-Paul Tran Thiet, Juliette Goyer, Julien Payré, The French Competition Authority announces the launch of an inquiry into the pharma sector, 26 February 2013, e-Competitions February 2013, Art. N° 51895

Visites 300

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues